BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6454406)

  • 21. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome.
    Wisniewski HM; Rabe A
    Ann N Y Acad Sci; 1986; 477():247-60. PubMed ID: 2949682
    [No Abstract]   [Full Text] [Related]  

  • 23. Familial Alzheimer's disease with myoclonus and 'spongy change'.
    Duffy P; Mayeux R; Kupsky W
    Arch Neurol; 1988 Oct; 45(10):1097-100. PubMed ID: 3178530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical expression of Alzheimer's disease in Down's syndrome.
    Dalton AJ; Crapper-McLachlan DR
    Psychiatr Clin North Am; 1986 Dec; 9(4):659-70. PubMed ID: 2949202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NIH Conference. Alzheimer's disease and Down's syndrome: new insights.
    Cutler NR; Heston LL; Davies P; Haxby JV; Schapiro MB
    Ann Intern Med; 1985 Oct; 103(4):566-78. PubMed ID: 2864010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
    Hanney M; Prasher V; Williams N; Jones EL; Aarsland D; Corbett A; Lawrence D; Yu LM; Tyrer S; Francis PT; Johnson T; Bullock R; Ballard C;
    Lancet; 2012 Feb; 379(9815):528-36. PubMed ID: 22236802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-infarct dementia in Down's syndrome.
    Collacott RA; Cooper SA; Ismail IA
    J Intellect Disabil Res; 1994 Apr; 38 ( Pt 2)():203-8. PubMed ID: 8193456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's disease in Down's syndrome: clinicopathologic studies.
    Wisniewski KE; Dalton AJ; McLachlan C; Wen GY; Wisniewski HM
    Neurology; 1985 Jul; 35(7):957-61. PubMed ID: 3159974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.
    Hyman BT; West HL; Rebeck GW; Lai F; Mann DM
    Arch Neurol; 1995 Apr; 52(4):373-8. PubMed ID: 7710373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of Alzheimer's disease and Creutzfeldt-Jakob's disease (author's transl)].
    Gaches J; Supino-Viterbo V; Foncin JF
    Acta Neurol Belg; 1977; 77(4):202-12. PubMed ID: 333854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alzheimer's disease in mongoloid idiocy (Down's trisomy)].
    Piessens FP; Overweg J
    Ned Tijdschr Geneeskd; 1971 Nov; 115(48):2018-20. PubMed ID: 4260153
    [No Abstract]   [Full Text] [Related]  

  • 33. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More on myoclonus in Alzheimer disease.
    Mayeux R; Hunter S; Fahn S
    Ann Neurol; 1980 Aug; 8(2):200. PubMed ID: 7425576
    [No Abstract]   [Full Text] [Related]  

  • 35. Magnetic resonance imaging, Down's syndrome and Alzheimer's disease: research and clinical implications.
    Prasher V; Cumella S; Natarajan K; Rolfe E; Shah S; Haque MS
    J Intellect Disabil Res; 2003 Feb; 47(Pt 2):90-100. PubMed ID: 12542574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dementia of Down's syndrome and its relevance to aetiological studies of Alzheimer's disease.
    Whalley LJ
    Ann N Y Acad Sci; 1982; 396():39-53. PubMed ID: 6217776
    [No Abstract]   [Full Text] [Related]  

  • 37. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.
    Wisniewski KE; Wisniewski HM; Wen GY
    Ann Neurol; 1985 Mar; 17(3):278-82. PubMed ID: 3158266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS).
    Möller JC; Hamer HM; Oertel WH; Rosenow F
    Seizure; 2001 Jun; 10(4):303-6. PubMed ID: 11466028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
    Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
    Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mapping of Alzheimer-type dementia in Down's syndrome.
    Prasher VP; Farrer MJ; Kessling AM; Fisher EM; West RJ; Barber PC; Butler AC
    Ann Neurol; 1998 Mar; 43(3):380-3. PubMed ID: 9506555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.